Maine Lawmakers Should Make a New Year’s Resolution to Prioritize Cancer Related Public Policy
The 2025 legislative session opens the door to an increased tax on all tobacco products and ensuring access to potentially lifesaving Biomarker testing
The 2025 legislative session opens the door to an increased tax on all tobacco products and ensuring access to potentially lifesaving Biomarker testing
The American Cancer Society joins the nation in mourning the loss of former president Jimmy Carter.
PROVIDENCE – December 28, 2024 – Starting the first of the year, menthol flavored e-cigarette products will still be on store shelves across Rhode Island.
This week, Congress failed to advance a bipartisan year-end health care package that would have made a big difference in the fight against cancer. The bill included language based on the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act (House)/ Medicare MCED Screening Coverage Act (Senate) and the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act, which are key priorities for cancer patients and their families.
MILWAUKEE, Wis. – Deb Nevels was awarded (ACT!) Lead of the Year by the American Cancer Society Cancer Action Network (ACS CAN) for her exceptional commitment to advocacy work and making cancer a national priority.
Public health and civil rights advocates celebrate the revival of the effort to end the sale of menthol cigarettes in New York City, coming later today when City Councilmember Rita Joseph will introduce legislation to reduce the heavy toll of menthol cigarettes on New Yorkers’ lives and lungs. Intro 1152 would prohibit the more than 5,000 licensed tobacco retailers in New York City from selling menthol cigarettes. The legislation is being championed by No More Menthols NYC-- a diverse, citywide campaign of civil rights and health advocates, including community groups, faith leaders, public health organizations and others.
Public health groups are applauding the U.S. Court of Appeals for the Fifth Circuit for upholding the non-discrimination provision of the Affordable Care Act (ACA) in the case of Neese v. Becerra. The court vacated a lower court ruling based on the plaintiffs’ lack of standing in the case, which challenged protections in the ACA for Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ+) patients receiving health care services.
This week, New Jersey lawmakers approved legislation to improve access to biomarker testing with a unanimous vote by the Assembly Appropriations Committee. Assembly Bill 4163 now awaits a vote on the Assembly floor. The Senate advanced identical legislation (Senate Bill 3098) in the Senate Commerce Committee last week, which now awaits further consideration by the Senate Budget & Appropriations Committee. Advocates with the New Jersey Biomarker Testing Coalition are hopeful that the bills will receive the necessary support to secure swift passage in the new year.
Today, the House released text of the FY25 Continuing Resolution and year-end health care package which includes language based on the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act (House)/ Medicare MCED Screening Coverage Act (Senate).
The Denver City Council voted 11-1 Monday evening to end the sale of most flavored tobacco products within city limits. While the American Cancer Society Cancer Action Network (ACS CAN) and its team of advocates, including cancer survivors and patients, are encouraged by the decision, the legislation includes an exemption for flavored hookah tobacco products which ACS CAN does not support.